Hercules Capital PE Ratio 2010-2024 | HTGC
Current and historical p/e ratio for Hercules Capital (HTGC) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Hercules Capital PE ratio as of November 12, 2024 is 9.60.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Hercules Capital PE Ratio Historical Data |
Date |
Stock Price |
TTM Net EPS |
PE Ratio |
2024-11-12 |
19.80 |
|
12.38 |
2024-09-30 |
19.64 |
$1.60 |
12.28 |
2024-06-30 |
19.92 |
$1.79 |
11.13 |
2024-03-31 |
17.53 |
$2.20 |
7.97 |
2023-12-31 |
15.43 |
$2.31 |
6.68 |
2023-09-30 |
14.75 |
$2.00 |
7.37 |
2023-06-30 |
12.91 |
$2.22 |
5.82 |
2023-03-31 |
10.86 |
$1.47 |
7.39 |
2022-12-31 |
10.81 |
$0.76 |
14.22 |
2022-09-30 |
9.14 |
$0.32 |
28.55 |
2022-06-30 |
10.30 |
$0.11 |
93.67 |
2022-03-31 |
13.38 |
$0.85 |
15.74 |
2021-12-31 |
11.94 |
$1.43 |
8.35 |
2021-09-30 |
11.69 |
$2.71 |
4.31 |
2021-06-30 |
11.74 |
$2.89 |
4.06 |
2021-03-31 |
10.78 |
$2.79 |
3.86 |
2020-12-31 |
9.47 |
$1.97 |
4.81 |
2020-09-30 |
7.38 |
$1.08 |
6.83 |
2020-06-30 |
6.50 |
$0.88 |
7.38 |
2020-03-31 |
4.59 |
$0.82 |
5.60 |
2019-12-31 |
8.18 |
$1.73 |
4.73 |
2019-09-30 |
7.61 |
$1.13 |
6.73 |
2019-06-30 |
7.11 |
$1.32 |
5.39 |
2019-03-31 |
6.85 |
$1.42 |
4.82 |
2018-12-31 |
5.84 |
$0.85 |
6.88 |
2018-09-30 |
6.78 |
$1.25 |
5.42 |
2018-06-30 |
6.37 |
$1.28 |
4.98 |
2018-03-31 |
5.95 |
$1.09 |
5.45 |
2017-12-31 |
6.28 |
$0.95 |
6.61 |
2017-09-30 |
6.04 |
$0.91 |
6.64 |
2017-06-30 |
6.05 |
$0.92 |
6.58 |
2017-03-31 |
6.75 |
$0.65 |
10.39 |
2016-12-31 |
6.17 |
$0.92 |
6.70 |
2016-09-30 |
5.79 |
$0.94 |
6.16 |
2016-06-30 |
5.19 |
$0.58 |
8.94 |
2016-03-31 |
4.89 |
$0.48 |
10.18 |
2015-12-31 |
4.83 |
$0.61 |
7.92 |
2015-09-30 |
3.89 |
$0.73 |
5.34 |
2015-06-30 |
4.34 |
$0.91 |
4.76 |
2015-03-31 |
4.94 |
$1.08 |
4.57 |
2014-12-31 |
5.33 |
$1.10 |
4.85 |
2014-09-30 |
5.08 |
$1.17 |
4.34 |
2014-06-30 |
5.57 |
$1.53 |
3.64 |
2014-03-31 |
4.74 |
$1.67 |
2.84 |
2013-12-31 |
5.42 |
$1.62 |
3.34 |
2013-09-30 |
4.95 |
$1.70 |
2.91 |
2013-06-30 |
4.44 |
$1.20 |
3.70 |
2013-03-31 |
3.82 |
$1.11 |
3.44 |
2012-12-31 |
3.40 |
$1.05 |
3.24 |
2012-09-30 |
3.29 |
$0.83 |
3.96 |
2012-06-30 |
3.31 |
$0.88 |
3.77 |
2012-03-31 |
3.17 |
$0.87 |
3.64 |
2011-12-31 |
2.64 |
$0.60 |
4.41 |
2011-09-30 |
2.33 |
$0.65 |
3.58 |
2011-06-30 |
2.81 |
$0.28 |
10.02 |
2011-03-31 |
2.87 |
$0.23 |
12.49 |
2010-12-31 |
2.65 |
$0.42 |
6.32 |
2010-09-30 |
2.54 |
$0.38 |
6.69 |
2010-06-30 |
2.27 |
$0.90 |
2.52 |
2010-03-31 |
2.56 |
$0.33 |
7.75 |
2009-12-31 |
2.46 |
$0.52 |
4.72 |
Sector |
Industry |
Market Cap |
Revenue |
Finance |
Finance - SBIC & Commercial |
$3.244B |
$0.461B |
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|